3.0.0 1717 2025-12-05T08:39:51Z 2025-12-05T08:39:51Z House H HR 2023-03-22 118 https://www.congress.gov/bill/118th-congress/house-bill/1717 <pre>[Congressional Record Volume 169, Number 52 (Wednesday, March 22, 2023)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Mr. NEGUSE:H.R. 1717.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8The single subject of this legislation is:Establish an interagency task force between the U.S. Patentand Trademark Office and the Food and Drug Administration forpurposes of sharing information with respect to patents.[Page H1329]</pre> hsju00 Judiciary Committee House Standing Referred To 2023-03-22T16:05:00Z 118 79 S 2023-03-01 Placed on Senate Legislative Calendar under General Orders. Calendar No. 18. Identical bill CRS 2023-03-22 Referred to the House Committee on the Judiciary. IntroReferral H11100 2 House floor actions hsju00 Judiciary Committee 2023-03-22 Introduced in House IntroReferral Intro-H 9 Library of Congress 2023-03-22 Introduced in House IntroReferral 1000 9 Library of Congress N000191 Rep. Neguse, Joe [D-CO-2] Joe Neguse D CO 2 N Commerce Commerce 2023-04-11T16:45:25Z

00 2023-03-22 Introduced in House 2023-10-16T11:25:48Z <p><b>Interagency Patent Coordination and Improvement Act of 2023 </b></p> <p>This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. </p> <p>The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the PTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the PTO, and (3) the PTO to assist the FDA in its ministerial role of listing patents.</p>

Display Title 45 2024-07-24T15:23:14Z Short Title(s) as Introduced 101 2024-05-24T13:41:32Z Introduced in House IH Official Title as Introduced 6 2024-03-18T20:29:33Z Introduced in House IH Introduced in House 2023-03-22T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118hr1717ih/xml/BILLS-118hr1717ih.xml 2023-03-22 Referred to the House Committee on the Judiciary. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.